Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Recurrent/Metastatic Endometrial Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Ended earlyNCT01132547
What this trial is testing

Cyproheptadine in Preventing Weight Loss in Children Receiving Chemotherapy for Cancer

Who this might be right for
Cancer
University of South Florida 22
Testing effectiveness (Phase 2)Ended earlyNCT02558348
What this trial is testing

Phase 1/2a Evaluation of AL3818 in Subjects With Recurrent or Metastatic Endometrial, Ovarian or Cervical Cancer (AL3818-US-001)

Who this might be right for
Endometrial CancerOvarian CancerCervical Cancer
Advenchen Laboratories, LLC 12
Testing effectiveness (Phase 2)UnknownNCT01100359
What this trial is testing

Liposome-Encapsulated Doxorubicin Citrate and Carboplatin in Treating Patients With Advanced or Metastatic Recurrent Endometrial Cancer

Who this might be right for
Endometrial Cancer
Medical University Innsbruck 39
Testing effectiveness (Phase 2)Ended earlyNCT01420081
What this trial is testing

Two Dual PI3K/mTOR Inhibitors, PF-04691502 And PF-05212384 In Patients With Recurrent Endometrial Cancer

Who this might be right for
Endometrial Neoplasms
Pfizer 67
Early research (Phase 1)Study completedNCT00268918
What this trial is testing

Docetaxel and PTK787 in Metastatic Breast Cancer Patients and Gynecological Cancer Patients

Who this might be right for
Ovarian CancerEndometrial CancerCervical Cancer+3 more
Dana-Farber Cancer Institute 24
Early research (Phase 1)Looking for participantsNCT07227168
What this trial is testing

STRO-004 in Adults With Refractory/Recurrent Metastatic Cancer

Who this might be right for
Head and Neck Squamous Cell Carcinoma HNSCCNon-Small Cell Lung Cancer NSCLCEsophageal Cancer+6 more
Sutro Biopharma, Inc. 200
Testing effectiveness (Phase 2)Study completedNCT00659360
What this trial is testing

AZD0530 in Treating Patients With Recurrent Locally Advanced or Metastatic Soft Tissue Sarcoma

Who this might be right for
Adult FibrosarcomaAdult LeiomyosarcomaAdult Liposarcoma+12 more
National Cancer Institute (NCI) 17
Testing effectiveness (Phase 2)Study completedNCT00030485
What this trial is testing

Erlotinib in Treating Patients With Locally Advanced and/or Metastatic Endometrial Cancer

Who this might be right for
Endometrial Cancer
National Cancer Institute (NCI)
Testing effectiveness (Phase 2)UnknownNCT04836663
What this trial is testing

TQ-B3525 Tablets in Subjects With PIK3CA and/or PIK3R1/2 Gene-altered Recurrent/Metastatic Advanced Gynecologic Tumors

Who this might be right for
Advanced Endometrial Cancer, Cervical Cancer and Ovarian Cancer
Chia Tai Tianqing Pharmaceutical Group Co., Ltd. 90
Testing effectiveness (Phase 2)UnknownNCT02982486
What this trial is testing

A Phase II of Nivolumab Plus Ipilimumab in Non-resectable Sarcoma and Endometrial Carcinoma

Who this might be right for
Soft Tissue SarcomaBone SarcomaChondrosarcoma+5 more
Assaf-Harofeh Medical Center 60
Testing effectiveness (Phase 2)Ended earlyNCT03572478
What this trial is testing

Rucaparib and Nivolumab in Patients With Prostate or Endometrial Cancer

Who this might be right for
Prostate CancerEndometrial Cancer
University of Chicago 12
Testing effectiveness (Phase 2)Study completedNCT01010126
What this trial is testing

Temsirolimus and Bevacizumab in Treating Patients With Advanced Endometrial, Ovarian, Liver, Carcinoid, or Islet Cell Cancer

Who this might be right for
Adult Hepatocellular CarcinomaAdvanced Adult Hepatocellular CarcinomaEndometrial Serous Adenocarcinoma+42 more
National Cancer Institute (NCI) 252
Not applicableLooking for participantsNCT03621904
What this trial is testing

PROMOTE Study: Prediction of Response Of HorMOnal Treatment in Advanced and Recurrent Endometrial Cancer

Who this might be right for
Endometrial Cancer Stage IIIEndometrial Cancer Stage IVEndometrial Cancer Recurrent
Radboud University Medical Center 150
Testing effectiveness (Phase 2)Looking for participantsNCT06330064
What this trial is testing

Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic Solid Tumors (IDeate-PanTumor02)

Who this might be right for
Recurrent or Metastatic Solid Tumors
Daiichi Sankyo 680
Testing effectiveness (Phase 2)Study completedNCT02632448
What this trial is testing

LY2880070 in Participants With Advanced or Metastatic Cancer

Who this might be right for
Solid TumorsColorectal CancerBreast Cancer+9 more
Esperas Pharma Inc. 229
Testing effectiveness (Phase 2)Ended earlyNCT03642990
What this trial is testing

NR in Chemo-induced Peripheral Neuropathy

Who this might be right for
Chemotherapy-induced Peripheral NeuropathyBreast Cancer MetastaticPlatinum-resistant Recurrent Ovarian Cancer+2 more
Donna Hammond, PhD 5
Large-scale testing (Phase 3)Study completedNCT00538850
What this trial is testing

Fentanyl Sublingual Spray in Treating Patients With Breakthrough Cancer Pain

Who this might be right for
Cancer
INSYS Therapeutics Inc 130
Testing effectiveness (Phase 2)Study completedNCT00478426
What this trial is testing

Sunitinib Malate in Treating Patients With Recurrent or Metastatic Endometrial Cancer

Who this might be right for
Endometrial AdenocarcinomaEndometrial Endometrioid AdenocarcinomaEndometrial Serous Adenocarcinoma+5 more
National Cancer Institute (NCI) 34
Testing effectiveness (Phase 2)Study completedNCT00072176
What this trial is testing

Temsirolimus in Treating Patients With Metastatic or Locally Advanced Recurrent Endometrial Cancer

Who this might be right for
Endometrial AdenocarcinomaEndometrial Adenosquamous Cell CarcinomaEndometrial Clear Cell Carcinoma+7 more
National Cancer Institute (NCI) 62
Early research (Phase 1)Study completedNCT00101972
What this trial is testing

RAV12 in Treating Patients With Metastatic or Recurrent Adenocarcinoma

Who this might be right for
Cancer
MacroGenics 53
Next Page